Top of this page
Skip navigation, go straight to the content
UCB is seeking to expand its pipeline and product portfolio with innovative products that will treat patients suffering from severe diseases. Our main areas of interest include:
| Neurology |
|---|
| Epilepsy |
| Parkinson's disease |
| Cognitive disorders |
| Orphan indication in neurology |
| Immunology |
| Rheumatology |
| Gastroenterology |
UCB is also interested in assessing commercial stage products assets complementary to UCB specific portfolios.